Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter

Multiple Sclerosis

Volumn 12, Issue 4, 2006, Pages 386-396

  Haddock, G ^a,b   Cross, A K ^a,b   Plumb, J ^a   Surr, J ^a,b   Buttle, D J ^b   Bunning, R A D ^a   Woodroofe, M N ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

ADAMTS; Extracellular matrix; Multiple sclerosis; TIMP 3

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; PROTEIN ADAMTS 1; PROTEIN ADAMTS 4; PROTEIN ADAMTS 5; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING; WHITE MATTER;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NERVE FIBERS, MYELINATED; PROCOLLAGEN N-ENDOPEPTIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-3; UP-REGULATION;

EID: 33746568333     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135248506ms1300oa     Document Type: Article

References (46)

1. Pangalos MN, Shioi J, Efthimiopoulos S, Wu A, Robakis NK. Characterization of appican, the chondroitin sulfate proteoglycan form of the Alzheimer amyloid precursor protein. Neurodegeneration 1996; 5: 445-51.
2. Bandtlow CE, Zimmermann DR. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000; 80: 1267-90.
3. Novak U, Kaye AH. Extracellular matrix and the brain: components and function. J Clin Neurosci 2000; 7: 280-90.
4. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000; 57: 276-89.
5. Inatani M, Honjo M, Otori Y, Oohira A, Kido N, Tano Y et al. Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture. Invest Ophthalmol Vis Sci 2001; 42: 1930-38.
6. Krekoski CA, Neubauer D, Zuo J, Muir D. Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan. J Neurosci 2001; 21: 6206-13.
7. Kurazono S, Okamoto M, Moris S, Matsui H. Recombinant core protein fragment of phosphocan, a brain specific chondroitin sulfate proteoglycan, promote excitotoxic cell death of cultured rat hippocampal neurons. Neurosci Lett 2001; 304: 169-72.
8. Sobel RA, Ahmed AS. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis. J Neuropathol Exp Neurol 2001; 60: 1198-207.
9. Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 2002; 22: 2225-36.
10. Zuo J, Neubauer D, Graham J, Krekoski CA, Ferguson TA, Muir D. Regeneration of axons after nerve transection repair is enhanced by degradation of chondroitin sulfate proteoglycan. Exp Neurol 2002; 176: 221-28.
11. Sobel RA. The extracellular matrix in multiple sclerosis lesions. J Neuropathol Exp Neurol 1998; 57: 205-17.
12. Apte SS. A disintegrin-like and metalloproteinase (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 2004; 36: 981-85.
13. Rawlings ND, O'Brien E, Barrett AJ. MEROPS: the protease database. Nucleic Acids Res 2002; 30: 343-46.
14. Vankemmelbeke MN, Holen I, Wilson AG, Ilic MZ, Handley CJ, Kelner GS et al. Expression and activity of ADAMTS-5 in synovium. Eur J Biochem 2001; 268: 1259-68.
15. Tang BL. ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 2001; 33: 33-44.
16. Porter S, Clark IM, Kevorkian L, Edwards D. The ADAMTS metalloproteinases. Biochem J 2005; 386: 15-27.
17. Kuno K, Matsushima K. ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type 1 motifs and its spacing region. J Biol Chem 1998; 273: 13912-17.
18. Vankemmelbeke MN, Jones GC, Fowles C, Ilic MZ, Handley CJ, Day AJ et al. Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. Eur J Biochem 2003; 270: 2394-403.
19. Somerville RPT, Longpre JM, Jungers KA, Engle JM, Ross M, Evanko S et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS sub-family related to Caenorhabditis elegans GON-1. J Biol Chem 2003; 278: 9503-13.
20. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 2001; 276: 13372-78.
21. 406 to generate glial hyaluronate binding protein. Biochem J 2004; 377: 787-95.
22. Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K, Arner EC, Hockfield S. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J Biol Chem 2000; 75: 22695-703.
23. Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett 2001; 494: 192-95.
24. Yu W-H, Yu SC, Meng Q, Brew K, Woessner JF. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000; 275: 31226-32.
25. Kashiwagi M, Tortorella M, Nagase H, Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAMTS4) and aggrecanase-2 (ADAM-TS5). J Biol Chem 2001; 276: 12501-504.
26. Bevitt DJ, Mohamed J, Catterall JB, Li Z, Arris CE, Hiscott P et al. Expression of ADAMTS metalloproteinases in the retinal pigment epithelium derived cell line ARPE-19: transcriptional regulation by TNFα. Biochim Biophys Acta 2003; 1626: 83-91.
27. Cross NA, Chandrasekharan S, Jokonya N, Fowles A, Hamdy FC, Buttle DJ et al. The expression and regulation of ADAMTS-1, -4, -5, -9 and -15, and TIMP-3 by TGFß in prostate cells: relevance to the accumulation of versican. Prostate 2005; 63: 269-75.
28. Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L et al. IL-1 beta induces COX2, MMP-1, -3 and 13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 2003; 21: 256-64.
29. Yamanishi Y, Boyle DL, Clark M, Maki RA, Tortorella MD, Arner EC et al. Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 2002; 168: 1405-12.
30. Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002; 12:154-69.
31. Hill HD, Straka JG. Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents. Anal Biochem 1988; 170: 203-208.
32. Jaworski DM, Fager N. Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development. J Neurosci Res 2000; 61: 396-408.
33. Arai M, Anderson D, Kurdi Y, Annis-Freeman B, Shields K, Collins-Racie LA et al. Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture system. Osteoarthritis Cartilage 2004; 12: 599-613.
34. Gao G, Westling J, Thompson VP, Howell TD, Gottschall PE, Sandy JD. Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C terminal truncation. J Biol Chem 2002; 277: 11034-41.
35. Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itoh Y et al. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 2004; 279: 10109-19.
36. Rodríguez-Manzaneque JC, Milchanowski AB, Dufour EK, Leduc R, Iruela-Arispe ML. Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. J Biol Chem 2000; 275: 33471-79.
37. Tortorella MD, Pratta M, Liu R-Q, Abbaszade I, Ross H, Burn T et al. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol Chem 2000; 275: 25791-97.
38. Flannery CR, Zeng W, Corcoran C, Collins-Racie LA, Chockalingam PS, Hebert Mackie SA et al. Autocatalytic cleavage of ADAMTS-4 (aggrecanase-1) reveals multiple glycosaminoglycan-binding sites. J Biol Chem 2002; 277: 42775-80.
39. Tortorella MD, Liu R-Q, Burn T, Newton RC, Arner E. Characterization of human aggrecanase 2 (ADAMTS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 2002; 21: 499-511.
40. Lemons ML, Sandy JD, Anderson DK, Howland DR. Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury. J Neurosci 2001; 21: 4772-81.
41. Sasaki M, Seo-Kiryu S, Kato R, Kita S, Kiyama H. A disintegrin and metalloproteinase with thrombospondin type 1 motifs (ADAMTS-1) and IL-1 receptor type 1 mRNAs are simultaneously induced in nerve injured motor neurons. Brain Res Mol Brain Res 2001; 89: 158-63.
42. Satoh K, Suzuki N, Yokota H. ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs) is transcriptionally induced in beta-amyloid treated astrocytes. Neurosci Lett 2000; 289: 177-80.
43. Yuan W, Matthews RT, Sandy JD, Gottschall PE. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 2002; 114: 1091-101.
44. Rodriguez-Manzaneque JC, Westling J, Thai SN, Luque A, Knauper V, Murphy G et al. ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun 2002; 293: 501-508.
45. Plumb J, Cross AK, Surr J, Haddock G, Smith T, Bunning RAD et al. ADAM-17 and TIMP-3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis. J Neuroimmunol 2005; 164: 1-9.
46. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ et al. TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998; 435: 39-44.